Temenos AG (ETR:TE8N)

Sage Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,214	4,986	6,051	3,685	8,707	8,272
Market Cap Growth	-12.22%	-17.60%	64.21%	-57.67%	5.25%	-17.29%
Enterprise Value	5,708	5,705	6,778	4,478	9,582	9,120
PE Ratio	20.30	29.14	49.67	34.42	57.11	57.81
PS Ratio	5.65	4.94	6.69	4.15	10.24	11.40
PB Ratio	11.47	8.08	9.81	6.81	20.86	19.33
P/FCF Ratio	17.79	14.41	20.82	13.99	21.91	26.91
P/OCF Ratio	17.57	14.21	20.21	13.22	21.52	26.42
EV/Sales Ratio	6.22	5.66	7.49	5.04	11.27	12.57
EV/EBITDA Ratio	23.70	23.23	33.42	25.26	40.47	44.50
EV/EBIT Ratio	26.87	25.54	37.58	29.15	45.49	52.36
EV/FCF Ratio	19.47	16.48	23.32	17.00	24.11	29.67
Debt / Equity Ratio	1.66	1.14	1.12	1.45	2.02	1.87
Debt / EBITDA Ratio	3.12	2.70	3.21	4.10	3.35	3.65
Debt / FCF Ratio	2.58	2.03	2.38	2.99	2.12	2.60
Asset Turnover	0.46	0.45	0.44	0.43	0.44	0.39
Quick Ratio	0.53	0.37	0.49	0.48	0.55	0.78
Current Ratio	0.53	0.59	0.49	0.48	0.55	0.78
Return on Equity (ROE)	48.96%	26.83%	21.37%	21.73%	34.74%	36.14%
Return on Assets (ROA)	6.64%	6.28%	5.47%	4.59%	6.73%	5.86%
Return on Capital (ROIC)	10.86%	10.28%	8.70%	7.19%	10.20%	8.53%
Return on Capital Employed (ROCE)	20.30%	19.20%	14.40%	12.50%	17.60%	13.00%
Earnings Yield	4.93%	3.43%	2.01%	2.90%	1.75%	1.73%
FCF Yield	5.62%	6.94%	4.80%	7.15%	4.57%	3.72%
Payout Ratio	36.66%	54.71%	65.54%	65.03%	41.20%	36.20%
Buyback Yield / Dilution	1.90%	-0.27%	-0.94%	0.58%	1.17%	0.35%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.